Humanized antibody compositions and methods for binding lysophosphatidic acid
View Patent ↗Compositions and methods for making and using humanized anti-LPA monoclonal antibodies, and fragments and derivatives thereof, are described.
1. An antibody or antigen-binding antibody fragment that binds lysophosphatidic acid (LPA) under physiological conditions, wherein each immunoglobulin heavy chain variable domain comprises the amino acid sequence of SEQ ID NO: 189 and each immunoglobulin light chain variable domain comprises the amino acid sequence of SEQ ID NO: 169.
2. An antibody or antigen-binding antibody fragment according to claim 1 that is selected from the group consisting of a full-length antibody or an Fab fragment.
3. An antibody or antigen-binding antibody fragment according to claim 1 that is a monoclonal antibody or an antigen-binding antibody fragment of a humanized antibody.
4. An antibody or antigen-binding antibody fragment according to claim 1 that is a humanized antibody or an antigen-binding antibody fragment of a humanized antibody.
5. A composition comprising a pharmaceutically acceptable carrier and an antibody or antigen-binding antibody fragment according to claim 1 .